YARROW BIOSCIENCE, INC. Proceeds from Sale of Available-for-sale Securities
YARROW BIOSCIENCE, INC. (YARW) reported Proceeds from Sale of Available-for-sale Securities of $14.04 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2019-10-31
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for the quarter ending 2019-09-30 was $0.00.
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for the quarter ending 2019-06-30 was $6.25M, a 525.00% increase year-over-year.
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for the quarter ending 2019-03-31 was $7.79M, a 90.05% increase year-over-year.
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for the quarter ending 2018-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for fiscal 2018 was $5.10M, a 15.00% decline from fiscal 2017.
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for fiscal 2017 was $6.00M, a 66.67% increase from fiscal 2016.
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for fiscal 2016 was $3.60M.
- YARROW BIOSCIENCE, INC. proceeds from sale of available-for-sale securities for fiscal 2015 was $0.00.
| Period end | Proceeds from Sale of Available-for-sale Securities 3 month | Proceeds from Sale of Available-for-sale Securities 6 month | Proceeds from Sale of Available-for-sale Securities 9 month | Proceeds from Sale of Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $6.25M derived: sum of 2 quarters · filed 2019-10-31 | $14.04M 10-Q · filed 2019-10-31 | $14.04M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | $6.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $14.04M 10-Q · filed 2019-08-01 | $14.04M derived: sum of 3 quarters · filed 2019-08-01 | $14.04M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-03-31 | $7.79M 10-Q · filed 2019-05-02 | $7.79M derived: sum of 2 quarters · filed 2019-05-02 | $7.79M derived: sum of 3 quarters · filed 2019-10-31 | $8.79M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $1.00M derived: sum of 3 quarters · filed 2019-10-31 | $5.10M 10-K · filed 2019-02-28 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.00M derived: sum of 2 quarters · filed 2019-10-31 | $5.10M 10-Q · filed 2019-10-31 | $5.10M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $5.10M 10-Q · filed 2019-08-01 | $5.10M derived: sum of 3 quarters · filed 2019-08-01 | $8.40M derived: sum of 4 quarters · filed 2019-08-01 |
| 2018-03-31 | $4.10M 10-Q · filed 2019-05-02 | $4.10M derived: sum of 2 quarters · filed 2019-05-02 | $7.40M derived: sum of 3 quarters · filed 2019-05-02 | $8.90M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.30M derived: sum of 2 quarters · filed 2019-02-28 | $4.80M derived: sum of 3 quarters · filed 2019-02-28 | $6.00M 10-K · filed 2019-02-28 |
| 2017-09-30 | $3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $4.80M derived: sum of 2 quarters · filed 2018-11-07 | $6.00M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $2.70M 10-Q · filed 2018-08-01 | ||
| 2017-03-31 | $1.20M 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $3.60M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |